Skip to main content
LQDA
NASDAQ Life Sciences

Director Stephen Bloch unloads $17.8M in Liquidia stock as insider distribution wave continues

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$86.22
Mkt Cap
$7.667B
52W Low
$16.82
52W High
$91.1
52W Position info
413% above low
Off High info
5.4% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

LQDA has more than doubled off its 52-week low of $16.82.

Summary

Liquidia Corp director Stephen Bloch sold $17.8 million in stock on July 22-23, continuing a 90-day trend of heavy insider selling with no offsetting purchases.


Key Events · Ownership and Investor Activity · LQDA

  • Director Sells $17.8M in Stock

    Stephen Bloch sold 200,000 shares at prices between $87.70 and $90.71 on July 22-23, 2026, for total proceeds of $17,786,409. The shares were held indirectly through Canaan VIII L.P.

  • Part of Broader Insider Selling Wave

    This sale contributes to a 90-day net insider selling total of $144.7 million across 13 insiders, with zero open-market purchases, signaling a persistent distribution trend.

  • Post-Sale Holdings Remain Substantial

    After the sales, Bloch still holds 664,071 shares indirectly and 71,594 shares directly, indicating continued but reduced exposure.


Analysis · LQDA · Life Sciences

Director Stephen Bloch sold $17.8 million of Liquidia Corp stock over two days, adding to a wave of insider selling that has seen over $144 million in open-market sales in the past 90 days with zero insider purchases. While Bloch is not a C-suite executive and the shares were held indirectly through Canaan VIII L.P., the sale is part of a persistent distribution pattern that raises questions about insider confidence despite the company's recent strong earnings and S&P SmallCap 600 inclusion.

At the time of this filing, LQDA was trading at $86.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.7B. The 52-week trading range was $16.82 to $91.10. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LQDA - Latest Insights

LQDA
Jun 12, 2026, 4:30 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $71.23
Real-time Price: $86.22 info
Change: +$14.99 (+21%) info
Market Cap: $7.667B info
LQDA
Jun 10, 2026, 4:52 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $65.31
Real-time Price: $86.22 info
Change: +$20.91 (+32%) info
Market Cap: $7.667B info
LQDA
Jun 08, 2026, 4:41 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $64.69
Real-time Price: $86.22 info
Change: +$21.53 (+33%) info
Market Cap: $7.667B info
LQDA
Jun 08, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $64.69
Real-time Price: $86.22 info
Change: +$21.53 (+33%) info
Market Cap: $7.667B info
LQDA
Jun 08, 2026, 4:11 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $63.90
Real-time Price: $86.22 info
Change: +$22.32 (+35%) info
Market Cap: $7.667B info